Connection

MACUS T KUO to Animals

This is a "connection" page, showing publications MACUS T KUO has written about Animals.
Connection Strength

0.415
  1. C-Jun N-terminal kinase signalling pathway in response to cisplatin. J Cell Mol Med. 2016 11; 20(11):2013-2019.
    View in: PubMed
    Score: 0.025
  2. Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy. Expert Opin Ther Targets. 2015; 19(10):1307-17.
    View in: PubMed
    Score: 0.023
  3. Overcoming platinum drug resistance with copper-lowering agents. Anticancer Res. 2013 Oct; 33(10):4157-61.
    View in: PubMed
    Score: 0.020
  4. Mechanistic basis for overcoming platinum resistance using copper chelating agents. Mol Cancer Ther. 2012 Nov; 11(11):2483-94.
    View in: PubMed
    Score: 0.019
  5. Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. Cancer Res. 2012 May 15; 72(10):2622-33.
    View in: PubMed
    Score: 0.018
  6. Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2009 Jan; 11(1):99-133.
    View in: PubMed
    Score: 0.015
  7. Molecular cloning of Chinese hamster 1q31 chromosomal fragile site DNA that is important to mdr1 gene amplification reveals a novel gene whose expression is associated with spermatocyte and adipocyte differentiation. Gene. 2006 May 10; 372:44-52.
    View in: PubMed
    Score: 0.012
  8. Association of fragile site-associated (FSA) gene expression with epithelial differentiation and tumor development. Biochem Biophys Res Commun. 2006 Feb 17; 340(3):887-93.
    View in: PubMed
    Score: 0.012
  9. 2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway. J Biol Chem. 2001 Jan 05; 276(1):413-20.
    View in: PubMed
    Score: 0.008
  10. Elevated expression of hepatic proliferative markers during early hepatocarcinogenesis in hepatitis-B virus transgenic mice lacking mdr1a-encoded P-glycoprotein. Mol Carcinog. 2000 Oct; 29(2):103-11.
    View in: PubMed
    Score: 0.008
  11. Chromosomal fragile sites and DNA amplification in drug-resistant cells. Biochem Pharmacol. 1998 Jul 01; 56(1):7-13.
    View in: PubMed
    Score: 0.007
  12. Wild-type p53-mediated induction of rat mdr1b expression by the anticancer drug daunorubicin. J Biol Chem. 1998 Jun 19; 273(25):15387-94.
    View in: PubMed
    Score: 0.007
  13. Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis. Int J Mol Sci. 2018 May 16; 19(5).
    View in: PubMed
    Score: 0.007
  14. Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues. Biochem Pharmacol. 1998 Mar 01; 55(5):605-15.
    View in: PubMed
    Score: 0.007
  15. Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea in human glioma cells. Cancer Res. 1997 Dec 01; 57(23):5292-9.
    View in: PubMed
    Score: 0.007
  16. Degradation of AMPK-a1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivation. Mol Oncol. 2017 12; 11(12):1806-1825.
    View in: PubMed
    Score: 0.007
  17. Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer. Oncotarget. 2017 Jul 25; 8(30):49275-49292.
    View in: PubMed
    Score: 0.007
  18. NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells. J Biol Chem. 1997 Jun 13; 272(24):15174-83.
    View in: PubMed
    Score: 0.007
  19. A novel cis-acting element is involved in the promoter activity of the rat mdr1b gene. Cell Growth Differ. 1996 Oct; 7(10):1369-81.
    View in: PubMed
    Score: 0.006
  20. Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers. Mol Carcinog. 2006 Sep; 45(9):701-9.
    View in: PubMed
    Score: 0.006
  21. BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma. Oncotarget. 2016 Apr 05; 7(14):17665-80.
    View in: PubMed
    Score: 0.006
  22. Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas. Hum Gene Ther. 1996 Feb 10; 7(3):355-65.
    View in: PubMed
    Score: 0.006
  23. Identification and characterization of a hepatoma cell-specific enhancer in the mouse multidrug resistance mdr1b promoter. J Biol Chem. 1995 Oct 27; 270(43):25468-74.
    View in: PubMed
    Score: 0.006
  24. Functional analysis of aryl hydrocarbon receptor nuclear translocator interactions with aryl hydrocarbon receptor in the yeast two-hybrid system. Biochem Pharmacol. 1995 Oct 12; 50(8):1295-302.
    View in: PubMed
    Score: 0.006
  25. Regulation of multidrug resistance gene mdr1b/mdr1 expression in isolated mouse uterine epithelial cells. J Cell Physiol. 1995 Jul; 164(1):132-41.
    View in: PubMed
    Score: 0.006
  26. Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin. Oncotarget. 2015 Mar 20; 6(8):6295-309.
    View in: PubMed
    Score: 0.006
  27. Malarial circumsporozoite protein is a novel gene delivery vehicle to primary hepatocyte cultures and cultured cells. J Biol Chem. 1995 Feb 24; 270(8):3667-76.
    View in: PubMed
    Score: 0.006
  28. Overexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin. Anticancer Res. 1994 Sep-Oct; 14(5A):1735-42.
    View in: PubMed
    Score: 0.005
  29. Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol Cell Biol. 1994 Aug; 14(8):5202-11.
    View in: PubMed
    Score: 0.005
  30. Retroviral delivery of DNA into the livers of transgenic mice bearing premalignant and malignant hepatocellular carcinomas. Hum Gene Ther. 1994 Jul; 5(7):845-52.
    View in: PubMed
    Score: 0.005
  31. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endocrinology. 1993 Aug; 133(2):521-8.
    View in: PubMed
    Score: 0.005
  32. Expression of multidrug-resistance (P-glycoprotein) genes in liver cancers: a molecular example of the convergence theory of hepatocarcinogenesis? Mol Carcinog. 1993; 7(2):73-5.
    View in: PubMed
    Score: 0.005
  33. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol Carcinog. 1993; 8(2):67-73.
    View in: PubMed
    Score: 0.005
  34. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell Growth Differ. 1992 Aug; 3(8):531-40.
    View in: PubMed
    Score: 0.005
  35. Isolation and characterization of putative intrinsic multidrug resistant Chinese hamster ovary cells by fluorescence activated cell sorting. Anticancer Res. 1992 Mar-Apr; 12(2):427-32.
    View in: PubMed
    Score: 0.005
  36. Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice. Int J Cancer. 2002 Jan 01; 97(1):52-7.
    View in: PubMed
    Score: 0.005
  37. Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site. DNA Cell Biol. 1991 Nov; 10(9):639-49.
    View in: PubMed
    Score: 0.004
  38. Analysis of the Chinese hamster P-glycoprotein/multidrug resistance gene pgp1 reveals that the AP-1 site is essential for full promoter activity. Cell Growth Differ. 1991 Sep; 2(9):429-37.
    View in: PubMed
    Score: 0.004
  39. Murine mdr-1, mdr-2, and mdr-3 gene expression: no coinduction with the Cyp1a-1 and Nmo-1 genes in liver by 2,3,7,8-tetrachlorodibenzo-p-dioxin. DNA Cell Biol. 1991 Jul-Aug; 10(6):433-41.
    View in: PubMed
    Score: 0.004
  40. Coordinate activation of multidrug-resistance (P-glycoprotein) genes mdr2 and mdr3 during mouse liver regeneration. Mol Carcinog. 1991; 4(5):358-61.
    View in: PubMed
    Score: 0.004
  41. Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas. Mol Cell Biol. 1990 Nov; 10(11):5728-35.
    View in: PubMed
    Score: 0.004
  42. Model for the formation of double minutes from prematurely condensed chromosomes of replicating micronuclei in drug-treated Chinese hamster ovary cells undergoing DNA amplification. Cancer Res. 1989 Dec 01; 49(23):6731-7.
    View in: PubMed
    Score: 0.004
  43. Expression of the P-glycoprotein gene in multidrug-resistant Chinese hamster ovary cells. Anticancer Res. 1989 May-Jun; 9(3):575-8.
    View in: PubMed
    Score: 0.004
  44. Expression of the mdr (P-glycoprotein) gene in Chinese hamster digestive tracts. J Natl Cancer Inst. 1988 Apr 20; 80(4):269-75.
    View in: PubMed
    Score: 0.003
  45. Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des. 2008; 14(11):1049-57.
    View in: PubMed
    Score: 0.003
  46. High-resolution mapping of DNase I hypersensitive site in the chicken beta-tubulin gene transfected into monkey cells. J Biol Chem. 1987 Jun 05; 262(16):7764-9.
    View in: PubMed
    Score: 0.003
  47. Specific gene amplification associated with consistent chromosomal abnormality in independently established multidrug-resistant Chinese hamster ovary cells. Chromosoma. 1987; 95(2):117-25.
    View in: PubMed
    Score: 0.003
  48. Multidrug-resistant phenotype cosegregates with an amplified gene in somatic cell hybrids of drug-resistant Chinese hamster ovary cells and drug-sensitive murine cells. Mol Cell Biol. 1986 Dec; 6(12):4268-73.
    View in: PubMed
    Score: 0.003
  49. DNA amplification in multidrug, cross-resistant Chinese hamster ovary cells: molecular characterization and cytogenetic localization of the amplified DNA. J Cell Biol. 1986 Oct; 103(4):1159-66.
    View in: PubMed
    Score: 0.003
  50. N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia. J Biol Chem. 2006 Sep 22; 281(38):28122-30.
    View in: PubMed
    Score: 0.003
  51. Re: How does the MRP/GS-X pump export doxorubicin? J Natl Cancer Inst. 1996 Apr 03; 88(7):466-8.
    View in: PubMed
    Score: 0.003
  52. The expression and chromatin structure of the chicken glyceraldehyde-3-phosphate dehydrogenase gene in mouse cells. J Biol Chem. 1985 Mar 10; 260(5):3071-8.
    View in: PubMed
    Score: 0.003
  53. Nick-translation of metaphase chromosomes: in vitro labeling of nuclease-hypersensitive regions in chromosomes. Proc Natl Acad Sci U S A. 1985 Feb; 82(3):854-8.
    View in: PubMed
    Score: 0.003
  54. Expression of endogenous murine leukemia virus in transplantable tumor cells and DNA methylation of the viral sequences. Cancer Res. 1984 Aug; 44(8):3518-21.
    View in: PubMed
    Score: 0.003
  55. Methylation of the alpha-fetoprotein gene in productive and nonproductive rat hepatocellular carcinomas. Cancer Res. 1984 Apr; 44(4):1642-7.
    View in: PubMed
    Score: 0.003
  56. Isolation and preliminary characterization of the synaptonemal complex from rat pachytene spermatocytes. Exp Cell Res. 1983 Mar; 144(1):63-72.
    View in: PubMed
    Score: 0.002
  57. Condensation of chromatin into chromosomes preserves an open configuration but alters the DNase I hypersensitive cleavage sites of the transcribed gene. Nucleic Acids Res. 1982 Aug 11; 10(15):4565-79.
    View in: PubMed
    Score: 0.002
  58. Analysis of DNA attached to the chromosome scaffold. J Cell Biol. 1982 May; 93(2):278-84.
    View in: PubMed
    Score: 0.002
  59. Comparison of chromosomal structures isolated under different conditions. Exp Cell Res. 1982 Mar; 138(1):221-9.
    View in: PubMed
    Score: 0.002
  60. Distribution of tightly bound proteins in the chicken ovalbumin gene region. Biochemistry. 1982 Jan 19; 21(2):321-6.
    View in: PubMed
    Score: 0.002
  61. Altered gel electrophoretic mobility of bleomycin-mediated release of nucleosomal DNA. Cancer Res. 1981 Jun; 41(6):2433-8.
    View in: PubMed
    Score: 0.002
  62. Preferential damage of active chromatin by bleomycin. Cancer Res. 1981 Jun; 41(6):2439-43.
    View in: PubMed
    Score: 0.002
  63. DNA methylation: correlation with DNase I sensitivity of chicken ovalbumin and conalbumin chromatin. Nucleic Acids Res. 1979 Dec 20; 7(8):2105-13.
    View in: PubMed
    Score: 0.002
  64. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene. 1999 Jul 29; 18(30):4371-82.
    View in: PubMed
    Score: 0.002
  65. Studies in heterochromatin DNA: accessibility of late replicating heterochromatin DNA in chromatin to micrococcal nuclease digestion. Chromosoma. 1979 Jan 08; 70(2):183-94.
    View in: PubMed
    Score: 0.002
  66. Studies in heterochromatin DNA: characterization of transcripts synthesized in situ from C-banded preparations. Chromosoma. 1978 Feb 24; 65(4):325-34.
    View in: PubMed
    Score: 0.002
  67. Location of messenger specifying sequences in mammalian chromosomes. Chromosoma. 1977 Sep 27; 63(3):241-52.
    View in: PubMed
    Score: 0.002
  68. Tyrosine kinase inhibition decreases Muc-1 expression in mouse epithelial cells. J Cell Physiol. 1997 Feb; 170(2):200-8.
    View in: PubMed
    Score: 0.002
  69. Report of the Third International Workshop on Human Chromosome 8 Mapping. San Antonio, Texas, October 25-27, 1996. Cytogenet Cell Genet. 1996; 75(2-3):71-84.
    View in: PubMed
    Score: 0.001
  70. In situ RNA synthesis in fixed mammalian chromosomes. Exp Cell Res. 1974 Oct; 88(2):424-7.
    View in: PubMed
    Score: 0.001
  71. Release of free bases from deoxyribonucleic acid after reaction with bleomycin. Mol Pharmacol. 1972 Sep; 8(5):531-7.
    View in: PubMed
    Score: 0.001
  72. Postnatal development of organic cation transport and mdr gene expression in mouse kidney. J Pharmacol Exp Ther. 1992 Jun; 261(3):1222-30.
    View in: PubMed
    Score: 0.001
  73. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells. Mol Pharmacol. 1991 Jan; 39(1):1-8.
    View in: PubMed
    Score: 0.001
  74. Biochemical and cytological studies of bleomycin actions on chromatin and chromosomes. Chromosoma. 1978 Sep 01; 68(3):229-40.
    View in: PubMed
    Score: 0.001
  75. Characterization of bleomycin-resistant DNA. Biophys J. 1973 Dec; 13(12):1296-306.
    View in: PubMed
    Score: 0.001
  76. Differential nuclease sensitivity of the ovalbumin and beta-globin chromatin regions in erythrocytes and oviduct cells of laying hen. Nucleic Acids Res. 1980 Jun 25; 8(12):2737-50.
    View in: PubMed
    Score: 0.001
  77. Genome analysis of Peromyscus (Rodentia, Cricetidae) VII. Localization of satellite DNA sequences and cytoplasmic poly(A) RNA sequences of P. eremicus on metaphase chromosomes. Chromosoma. 1977 Nov 14; 64(2):133-42.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.